New hip device aims to delay full replacement

NCT ID NCT06792539

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This trial tests a new hip resurfacing system in 238 adults with hip osteoarthritis or mild dysplasia. The device is designed to cap the damaged joint rather than replace the entire hip. Researchers will compare pain, function, and safety to standard total hip replacement over two years.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Polymotion Hip Resurfacing (PHR) System (a surgical device)
What this could lead to
If successful, this could offer a less invasive hip replacement option that preserves more bone and may delay the need for a full hip replacement.
What could go wrong
This is a non-randomized trial, so results may be biased. The device is still being tested for safety and effectiveness, and long-term outcomes are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEGENERATIVE JOINT DISEASE OF HIP are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Florida Medical Clinic Orlando Health

    Tampa, Florida, 33613, United States

  • Hampton Road Orthopaedics

    Newport News, Virginia, 23606, United States

  • Joint Implant Surgeons

    New Albany, Ohio, 43054, United States

  • Midlands Orthopaedics & Neurosurgery

    Columbia, South Carolina, 29210, United States

  • NYU Longone

    New York, New York, 10003, United States

  • Oregon Health & Science University

    Portland, Oregon, 97239, United States

  • Orthopaedic and Physiotherapy Associates

    Paget, Trevelyan, DV04, Bermuda

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

  • Sinai Hospital / LifeBridge Health

    Baltimore, Maryland, 21215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.